[161Tb]Tb-PSMA-617

N/A

Report date: 2025/11/14 09:32:36

NME

Base Information

Drug Name[161Tb]Tb-PSMA-617

Drug Alias Name[161Tb]Tb-PSMA-617

ClassificationRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPaul Scherrer Institute,Villigen,Switzerland

China Registration ClassN/A

Develop Information

Active CompaniesPaul Scherrer Institute,Villigen,Switzerland

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A